The impact of the committee’s failure on physicians is 2-fold: a missed opportunity to repeal Medicare’s sustainable growth rate formula and a 2% pay cut for Medicare providers in 2013. Medscape Medical News
Month: November 2011
Regeneron’s Eylea for treating age related macular degeneration gets FDA nod
Regeneron Pharmaceuticals has received marketing approval for their eye drug – Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat “wet” age-related macular degeneration. The only other drug ap…
Surgery Outcomes Better With Some Fat on the Bones (CME/CE)
(MedPage Today) — Surgical patients with a body mass index at the lower end of the normal range were more likely to die within 30 days of the procedure than those in the moderately overweight range, researchers found.
Horizon scanning: US FDA approves aflibercept (Eylea®) for wet age-related macular degeneration
Source: FDA
Area: News
The US FDA has approved aflibercept (Eylea®) for the treatment of wet (neovascular) age-related macular degeneration (AMD). Aflibercept is administered as an intravitreal injection (given by an ophthalmologist) every 4-8 …
Retina Implant scientific advisory board approves multi-center phase of second human clinical trial
Retina Implant AG, the leading developer of subretinal implants for retinitis pigmentosa patients, today announced that its scientific advisory board is in full support of beginning the multi-center phase of the Company’s second human clinical trial. T…
Nudity Tunes Up The Brain
Researchers at the University of Tampere and the Aalto University, Finland, have shown that the perception of nude bodies is boosted at an early stage of visual processing. The research was funded by the Academy of Finland. Most people like to look at …
A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease
Status: Not yet recruiting,
Condition Summary: Dry Eye Disease
Eylea Approved For Age-related Macular Degeneration, USA
Eylea (aflibercept) has been approved by the FDA for wet AMD (age-related macular degeneration). Wet (neovascular) AMD is one of the main causes of blindness or vision impairment in older Americans – by affecting the part of the eye that allows us to s…
Synesthesia: Brain Study Explores What Makes Colors And Numbers Collide
Someone with the condition known as grapheme-color synesthesia might experience the number 2 in turquoise or the letter S in magenta. Now, researchers reporting their findings online in the Cell Press journal Current Biology have shown that those indiv…
FDA Approves Eylea for Macular Degeneration
(MedPage Today) — The FDA has approved a first-in-class drug, aflibercept (Eylea), for “wet” age-related macular degeneration, its manufacturer announced.
Visual Impairment Becoming Less Likely in Diabetes
People with diabetes were significantly less likely to report visual impairment in 2010 than in 1997, but blacks did not show the same improvements as the rest of the population. Medscape Medical News
FDA Approves Eylea For Eye Disorder In Older People
The U.S. Food and Drug Administration approved Eylea (aflibercept) to treat patients with wet (neovascular) age-related macular degeneration (AMD), a leading cause of vision loss and blindness in Americans ages 60 and older. AMD gradually destroys a …
FDA approves EYLEA for treatment of wet Age-related Macular Degeneration
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection, known in the scientific literature as VEGF Trap-Eye, for the treatment of patients with neovascular (wet) Age-related…
Super Committee on Hook for Deficit-Reduction Plan Monday
A more important deadline is November 23. The committee must approve a plan by then to shrink the deficit by at least $1.2 trillion, lest automatic cuts ensue, including those for Medicare providers. Medscape Medical News
FDA Approves Aflibercept for Age-Related Macular Degeneration
The US Food and Drug Administration has approved an aflibercept ophthalmic solution for the treatment of neovascular (“wet”) age-related macular degeneration. FDA Approvals
Retinol May Counteract the Negative Effect of Cadmium on Bone
European CHMP adopts positive opinion on new indication for nepafenac (Nevanac)
Source: European Medicines Agency
Area: News
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion on a new indication for nepafenac (Nevanac) as follows:
“Reduction in t…
The Eye Of The Fly: Researchers Discover Possible Key To Degenerative Nerve Diseases
Researchers at the University of Wisconsin-Madison and collaborators have discovered a powerful new protein in the eye of the fruit fly that may shed light on blinding diseases and other sensory problems in humans. Reporting in the Nov…
New protein in the fruit fly eye may shed light on neurodegenerative diseases
Researchers at the University of Wisconsin-Madison and collaborators have discovered a powerful new protein in the eye of the fruit fly that may shed light on blinding diseases and other sensory problems in humans.
Melatonin for non-respiratory sleep disorders in visually impaired children
Source: Cochrane Library
Area: Evidence > Drug Specific Reviews
Background
Exogenous melatonin helps in regulating the circadian rhythm and is widely used for the management of sleep disorders in visually impaired children.
Ob…